Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment

Circulation

Volumn 103, Issue 3, 2001, Pages 351-356

  Gieffers, Jens ^a   Füllgraf, Henriette ^a   Jahn, Jürgen ^a   Klinger, Matthias ^a   Dalhoff, Klaus ^a   Katus, Hugo A ^a   Solbach, Werner ^a   Maass, Matthias ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Atherosclerosis; Azithromycin; Chlamydia pneumoniae; Infection; Rifampin

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; MESSENGER RNA; RIFAMPICIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIUM CULTURE; BACTERIUM DETECTION; CASE REPORT; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPORT KINETICS; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 0035936544     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.3.351     Document Type: Article

References (31)

1. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease
2. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary arteriosclerosis
3. Atheroma: More than mush
4. Atherosclerosis: An inflammatory disease
5. Antibiotic treatment trials for secondary prevention of coronary artery disease events
6. Activity of antibiotics in eliminating Chlamydia pneumoniae cardiovascular strains from cell types involved in the pathogenesis of arteriosclerosis
7. The immunobiology and immunopathology of chlamydial infections
8. Morphologic and antigenetic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro
9. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
10. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors
11. Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease
12. Chlamydia pneumoniae infection in human monocytes
13. In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries
14. Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene
15. Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction
16. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
17. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular diseases
18. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
19. Chlamydia pneumoniae in atheroma: Consideration of criteria for causality
20. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response
21. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells
22. Molecular mediators of arterial inflammation: A role for microbial products?
23. Ultrastructural and molecular analysis of the persistence of Chlamydia trachomatis (serovar K) in human monocytes
24. Persistent infection with Chlamydia pneumoniae following acute respiratory illness
25. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: Primary clinical results of the ACADEMIC study
26. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes
27. Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline
28. Antibiotics and risk of subsequent first-time acute myocardial infarction
29. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
30. In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model
31. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence